Compound betamethasone
Phase 3Small molecule
Compound betamethasone is one of 15 small molecule programs targeting Sarcoidosis, Pulmonary. It is currently in Phase 3.
3
Indications
10
Total Trials
4
Active Trials
14
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
15 competitors in Frozen Shoulder
#DrugCompanyPhaseTrials
1Medrol
PfizerApproved
Elavil
AstraZenecaApproved
Decadron
AAspen Global Incorporated
Approved
Aspercreme Warming
AAveritas Pharma, Inc.
Approved
Rayos
RRoxane Laboratories
Approved
Xylocaine
MMEDRx USA, Inc.
Approved
Deltasone
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Avastin
RochePhase 2
Compound betamethasone
SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
Bayer Aspirin
BayerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Frozen Shoulder3 trials
Ultrasound-Guided Intra-Articular vs Gluteal Intramuscular Corticosteroid Injection for Frozen Shoulder
Recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 4·NCT07416916·528 enrolled
Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder
Terminated·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 4·NCT04931511·20 enrolled
Monoclonal2 trials
A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout
Unknown status·SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.·Phase 1/2·NCT05588908·120 enrolled
A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout
Unknown status·SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.·Phase 3·NCT06169891·500 enrolled
Arthritis1 trial
Injury1 trial
2 more indications
Mesenchymal Stem Cells1 trial
Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells
Unknown status·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 2·NCT03279796·200 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Compound betamethasone. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details